Epic Develops AI Agents to Manage Routine Patient Visits
The research-stage tools aim to automate follow-up care and free physician time as workforce shortages persist.
Updated on Oct. 20, 2026 in Artificial Intelligence

Live Poll
Would you trust an AI agent to conduct portions of your routine medical follow-up visits?
Epic is currently in the discovery phase of developing AI agents designed to manage routine clinical patient visits. These research-stage tools are intended to automate follow-up care by gathering data and comparing it against established clinical protocols before a physician review.
Why it matters
The project seeks to mitigate appointment backlogs caused by healthcare workforce shortages and improve access for patients facing insurance or funding barriers. By shifting routine monitoring to AI agents, the company aims to prioritize physician time for higher-acuity cases.
The development utilizes tools dubbed Agent Factory, Art, and Emmie to execute clinical protocols. These systems evaluate patient information against human-defined standards, with performance currently measured by their ability to prepare data for final physician determination.
The players
Epic
A developer of electronic health record software that supports clinical workflows and administrative data management for large health systems.
The details
The AI agents function by collecting patient-reported information and assessing it against pre-set clinical protocols. The system then compiles the reviewed data and findings for a physician to conduct a final verification and determination. This process is currently in a research-stage discovery phase, with no organizations yet using the tools in live patient care.
Timeline
October 13, 2026: Epic's senior vice president detailed the company's AI strategy at Harvard.
The Tech Race
This development moves beyond current AI-driven scribing tools by attempting to automate the execution of medical protocols rather than just capturing notes. It reflects a broader shift toward diagnostic-adjacent AI in hospital infrastructure.
These agents aim to enable remote handling of routine follow-up care, potentially reducing the need for in-person appointments for some patients. As the technology remains in the discovery phase, specific deployment dates and clinical availability are not yet set.
The takeaway
The move signals a transition toward AI-assisted clinical decision-making to address staffing shortages. Readers should watch for future announcements regarding pilot site clinical trials to confirm if these agents can effectively manage protocols without human intervention.
Further reading
For broader trends in medical automation, explore the Artificial Intelligence section.
Live Poll
Would you trust an AI agent to conduct portions of your routine medical follow-up visits?









